Recent Review Articles

Belongia EA. et al. Repeated annual influenza vaccination and vaccine effectiveness: Review of evidence. Expert Rev Vaccines. 2017 May 31.
Abstract

Bhatnagar S, Dave K, Venuganti VVK. Microneedles in the clinic. J Control Release. 2017 May 23. pii: S0168-3659(17)30603-X.
Abstract

Haugh M. et al. A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries. Expert Rev Vaccines. 2017 Jun;16(6):545-564.
Abstract

Review Articles – Influenza Vaccines
2012 – May 2017

Ansaldi F. et al.Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults. Expert Rev Vaccines. 2012 Jan;11(1):17-25.
Abstract

Balasingam S, Wilder-Smith A. Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies. Int J Infect Dis. 2016 May 18. pii: S1201-9712(16)31056-6.
Full text

Bandell AR, Simões EA. Live attenuated influenza vaccine tetravalent: a clinical review. Expert Rev Vaccines. 2015 Apr 11:1-11.
Abstract

Barrett PN, Portsmouth D, Ehrlich HJ. Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development. Expert Rev Vaccines. 2013 Apr;12(4):395-413.
Abstract

Belongia EA. et al. Repeated annual influenza vaccination and vaccine effectiveness: Review of evidence. Expert Rev Vaccines. 2017 May 31.
Abstract

Belongia EA. et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016 Apr 6. pii: S1473-3099(16)00129-8.
Abstract

Bhatnagar S, Dave K, Venuganti VVK. Microneedles in the clinic. J Control Release. 2017 May 23. pii: S0168-3659(17)30603-X.
Abstract

Black S. Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults. Vaccine. 2015 Jun 8;33 Suppl 2:B3-B5.
Full text

Breteler JK et al. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: A systematic review and meta-analysis. Vaccine. 2013 Sep 5. pii
Abstract

Chan CY, Tambyah PA. Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine. Expert Rev Vaccines. 2012 Jul;11(7):759-73. doi: 10.1586/erv.12.55.
Abstract

Childress BC, Montney JD, Albro EA. Making evidence-based selections of influenza vaccines. Hum Vaccin Immunother. 2014 Jun 18;10(9).
Abstract

Chiu C. et al. Cross-reactive humoral responses to influenza and their implications for a universal vaccine Ann N Y Acad Sci 2013 Apr;1283:13-21. doi: 10.1111/nyas.12012. Epub 2013 Feb 13.
Full text

Cho A, Wrammert J. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Curr Opin Virol. 2016 Mar 28;17:110-115.
Abstract

Christopoulou I. et al. Influenza vaccines to control influenza-associated bacterial infection: where do we stand? Expert Rev Vaccines. 2014 Sep 11:1-13.
Abstract

Clegg CH, Rininger JA, Baldwin SL. Clinical vaccine development for H5N1 influenza. Expert Review of Vaccines July 2013, Vol. 12, No. 7, Pages 767-777
Abstract

Cobey S, Hensley SE. Immune history and influenza virus susceptibility. Curr Opin Virol. 2017 Jan 12;22:105-111.
Abstract

Coelingh KL. et al. Development of live attenuated influenza vaccines against pandemic influenza strains. Expert Rev Vaccines. 2014 Jul;13(7):855-71.
Abstract

Del Giudice G, Rappuoli R. Inactivated and Adjuvanted Influenza Vaccines. Curr Top Microbiol Immunol. 2014 Jul 20.
Abstract

Deng M.P. et al. Developments of subunit and VLP vaccines against influenza A virus. Virol Sin. 2012 Jun;27(3):145-53. doi: 10.1007/s12250-012-3241-1. Epub 2012 Jun 9.
Abstract

Devarajan P. et al. New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza. Front Immunol. 2016 Apr 11;7:136.
Full text

de Vries RD, Rimmelzwaan GF. Viral vector-based influenza vaccines. Hum Vaccin Immunother. 2016 Jul 25:0.
Abstract

de Vries RD. et al. Universal influenza vaccines: a realistic option? Clin Microbiol Infect. 2016 Apr 26. pii: S1198-743X(15)01031-9.
Abstract

de Vries RD, Altenburg AF, Rimmelzwaan GF. Universal influenza vaccines, science fiction or soon reality? Expert Rev Vaccines. 2015 Jun 23:1-3.
Abstract

Dewe W, Benoit A, Legrand C. Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties. Expert Rev Clin Pharmacol. 2013 Jul;6(4):403-11.
Abstract

DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine. 2012 Dec 17;31(1):49-57.
Abstract

Dormitzer PR, Tsai TF, Del Giudice G. New technologies for influenza vaccines. Hum Vaccin Immunother. 2012 Jan;8(1):45-58.
Abstract

Esposito S. et al. Live attenuated intranasal influenza vaccine. Hum Vaccin Immunother. 2012 Jan;8(1):76-80.
Abstract

Even-Or O. et al. Adjuvanted influenza vaccines. Expert Rev Vaccines. 2013 Sep;12(9):1095-108
Abstract

Fielding JE. Influenza vaccine effectiveness using the test-negative design: comparability and methodological challenges in meta-analyses. (Australia) Lancet Respir Med. 2017 Mar;5(3):161-162.
Abstract

Ge SQ, Wang ZL. [Progress in development of influenza virus-like particles].[Article in Chinese] Bing Du Xue Bao. 2013 Mar;29(2):224-32.
Abstract

Gilbert SC. Advances in the development of universal influenza vaccines. Influenza Other Respi Viruses. 2013 Sep;7(5):750-8.
Abstract

Gill H.S. et al. Cutaneous immunization: an evolving paradigm in influenza vaccines. Expert Opin Drug Deliv. 2014 Feb 12. [Epub ahead of print]
Abstract

Gomez Lorenzo MM, and Fenton MJ. Immunobiology of influenza vaccines. Chest 2013 Feb 1;143(2):502-10. doi: 10.1378/chest.12-1711.
Abstract

Hannoun C. The evolving history of influenza viruses and influenza vaccines. Expert Rev Vaccines. 2013 Sep;12(9):1085-94.
Abstract

Haugh M. et al. A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries. Expert Rev Vaccines. 2017 Jun;16(6):545-564.
Abstract

Hensley SE. Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr Opin Virol. 2014 Aug 7;8C:85-89.
Abstract

Houser K1, Subbarao K. Influenza Vaccines: Challenges and Solutions. Cell Host Microbe. 2015 Mar 11;17(3):295-300
Abstract

Huzair F. The influenza vaccine innovation system and lessons for PDPs. Hum Vaccin Immunother. 2012 Mar;8(3):407-10.
Abstract

Icardi G. et al. Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system. Hum Vaccin Immunother. 2012 Jan;8(1):67-75. Jan 1.
Full text

Isakova-Sivak I, Rudenko L. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines. Expert Rev Vaccines. 2015 Aug 6:1-17. 2015
Abstract

Jang YH, Seong BL. Cross-protective immune responses elicited by live attenuated influenza vaccines. Yonsei Med J. 2013 March 1; 54(2): 271–282.
Full text

Jin H, Chen Z. Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses. Curr Opin Virol. 2014 Apr 2;6C:34-39.
Abstract

Jin H, Subbarao K. Live Attenuated Influenza Vaccine. Curr Top Microbiol Immunol. 2014 Jul 25.
Abstract

Kang SM, Song JM, Kim YC. Microneedle and mucosal delivery of influenza vaccines. Expert Rev Vaccines. 2012 May;11(5):547-60.
Abstract

Kang SM, Compans RW. Virus-like particles as universal influenza vaccines. Expert Rev Vaccines. 2012 Aug;11(8):995-1007.
Full text

Kelso JM. Safety of influenza vaccines. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):383-8.
Abstract

Kim TH. Seasonal influenza and vaccine herd effect. (Republic of Korea) Clin Exp Vaccine Res. 2014 Jul;3(2):128-32.
Full text

Kirchenbaum GA, Ross TM. Eliciting broadly protective antibody responses against influenza. Curr Opin Immunol. 2014 Jun;28C:71-76.
Abstract

Kolpe A. et al. M2-based influenza vaccines: recent advances and clinical potential. Expert Rev Vaccines. 2016 Sep 22.
Abstract

Krammer F. Emerging influenza viruses and the prospect of a universal influenza virus vaccine. Biotechnol J. 2015 May;10(5):690-701.
Abstract

Krammer F, Palese P. Advances in the development of influenza virus vaccines. Nat Rev Drug Discov. 2015 Feb 27;14(3):167-82.
Abstract

Kuritzky LA, Pratt M. Systemic Allergic Contact Dermatitis After Formaldehyde-Containing Influenza Vaccination. J Cutan Med Surg. 2015 Apr 15. pii: 1203475415582306
Abstract

Lambach P. et al. Considerations of strategies to provide influenza vaccine year round. Vaccine. 2015 Aug 28. pii: S0264-410X(15)01164-0.
Full text

Leung VK. et al. Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review. Euro Surveill. 2016 Apr 21;21(16).
Abstract

Liu Y. et al. Review of 10 years of clinical experience with Chinese domestic trivalent influenza vaccine Anflu®. Hum Vaccin Immunother. 2013 Oct 8;10(1). [Epub ahead of print]
Abstract

López-Macías C. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccin Immunother. 2012 Mar;8(3):411-4. Feb 14.
Full text

Luo DY, Xue CY, Cao YC. [Research progress and prospect of universal influenza vaccine]. [Article in Chinese] Bing Du Xue Bao. 2013 Nov;29(6):646-50.
Abstract

Manceur AP, Kamen AA. Critical review of current and emerging quantification methods for the development of influenza vaccine candidates. Vaccine. 2015 Aug 10. pii: S0264-410X(15)01108-1.
Abstract

Marcelin G, Sandbulte MR, Webby RJ. Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines. Rev Med Virol. 2012 Jul;22(4):267-79.
Full text

Marra F. et al. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza Other Respi Viruses. 2013 Jul;7(4):584-603. doi: 10.1111/irv.12000. Epub 2012 Sep 13.
Abstract

Martín Arias LH. et al. Guillain-Barré syndrome and influenza vaccines: A meta-analysis. Vaccine. 2015 May 18. pii: S0264-410X(15)00634-9.
Abstract

Milián E, Kamen AA. Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines. Biomed Res Int. 2015;2015:504831.
Full text 

Montomoli E. et al. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. Expert Rev Vaccines. 2012 May;11(5):587-94.
Abstract

Moro P.L. et al. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev Vaccines. 2012 Aug;11(8):911-21.
Abstract

Nachbagauer R, Krammer F. Universal influenza virus vaccines and therapeutic antibodies. Clin Microbiol Infect. 2017 Feb 12. pii: S1198-743X(17)30097-6.
Abstract

Neu KE. et al. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease? Curr Opin Immunol. 2016 Jun 3;42:48-55.
Abstract

Noah DL, Noah JW. Adapting global influenza management strategies to address emerging viruses. Am J Physiol Lung Cell Mol Physiol. 2013 Jul 15;305(2):L108-17.
Abstract

Nogales A, Martínez-Sobrido L. Reverse Genetics Approaches for the Development of Influenza Vaccines. Int J Mol Sci. 2016 Dec 22;18(1). pii: E20.
Full text

O'Hagan D.T. et al. The mechanism of action of MF59 - an innately attractive adjuvant formulation.Vaccine. 2012 Jun 19;30(29):4341-8. doi: 10.1016/j.vaccine.2011.09.061.
Abstract

Osterholm M.T. et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012 Jan;12(1):36-44.
Abstract

Ott JJ. et al. Influenza vaccines in low and middle income countries: A systematic review of economic evaluations. Hum Vaccin Immunother 2013 May 31;9(7). [Epub ahead of print]
Abstract

Palache A. et al. Seasonal influenza vaccine dose distribution in 157 countries (2004-2011). Vaccine. 2014 Nov 12;32(48):6369-6376.
Full text

Pedersen G, Cox R. The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza. Hum Vaccin Immunother. 2012 May;8(5):689-93.
Abstract

Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annual Review of Medicine Vol. 64: 189-202 (Volume publication date January 2013)
Abstract

Posteraro B.The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses. Vaccine. 2014 Feb 7. pii: S0264-410X(14)00109-1.
Abstract

Principi N, Esposito S. Adjuvanted influenza vaccines. Hum Vaccin Immunother. 2012 Jan;8(1):59-66.
Abstract

Pronker ES, Claassen E, Osterhaus AD. Development of new generation influenza vaccines: recipes for success? Vaccine. 2012 Dec 7;30(51):7344-7. doi: 10.1016/j.vaccine.2012.09.071. Epub 2012 Oct 5.
Abstract

Reber A, Katz J. Immunological assessment of influenza vaccines and immune correlates of protection. Expert Rev Vaccines. 2013 May;12(5):519-36. doi: 10.1586/erv.13.35.
Abstract

Remschmidt C, Wichmann O, Harder T. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis. 2015 Oct 17;15:429.
Full text

Remschmidt C., Wichmann O., Harder T. Methodological quality of systematic reviews on influenza vaccination. Vaccine. 2014 Feb 7. pii: S0264-410X(14)00112-1.
Abstract

Ren H, Zhou P. Epitope-focused vaccine design against influenza A and B viruses. Curr Opin Immunol. 2016 Jun 22;42:83-90.
Abstract

Ren J., et al. Meta analysis on the immunogenicity of domestic influenza virus vaccines. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.2013 Sep;29(9):981-5. [Article in Chinese]
Abstract

Robertson CA. et al. Fluzone® High-Dose Influenza Vaccine. Expert Rev Vaccines. 2016 Dec;15(12):1495-1505. Epub 2016 Nov 14.
Abstract

Rose MA, Zielen S, Baumann U. Mucosal immunity and nasal influenza vaccination. Expert Rev Vaccines. 2012 May;11(5):595-607. doi: 10.1586/erv.12.31.
Abstract

Saitoh A, Okabe N. Recent progress and concerns regarding the Japanese immunization program: Addressing the "vaccine gap" Vaccine. 2014 Jul 23;32(34):4253-4258.
Abstract

Samaan G, McPherson M, Partridge J. A Review of the Evidence to Support Influenza Vaccine Introduction in Countries and Areas of WHO's Western Pacific Region PLoS One. 2013 Jul 16;8(7):e70003. doi: 10.1371/journal.pone.0070003. Print 2013
Full text

Shaw A. New technologies for new influenza vaccines. Vaccine. 2012 Jul 13;30(33):4927-33.
Abstract

Schotsaert M, García-Sastre A. Influenza Vaccines: A Moving Interdisciplinary Field. Viruses. 2014 Oct 9;6(10):3809-3826.
Full text

Schotsaert M, Saelens X, Leroux-Roels G. Influenza vaccines: T-cell responses deserve more attention. Expert Rev Vaccines. 2012 Aug;11(8):949-62.
Abstract 

Shriver Z, Trevejo JM, Sasisekharan R. Antibody-Based Strategies to Prevent and Treat Influenza. Front Immunol. 2015 Jul 13;6:315.
Full text

Skountzou I, Compans RW. Skin immunization with influenza vaccines. Curr Top Microbiol Immunol. 2015;386:343-69.
Abstract

Soema PC. et al. Current and next generation influenza vaccines: Formulation and production strategies. Eur J Pharm Biopharm. 2015 Jun 3. pii: S0939-6411(15)00255-6.
Full text

Song JM. Advances in novel influenza vaccines: a patent review. J Microbiol. 2016 Jun;54(6):403-12.
Abstract

Sparrow E. et al. Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine. 2016 Sep 9. pii: S0264-410X(16)30744-7.
Abstract

Stachyra A, Góra-Sochacka A, Sirko A. DNA vaccines against influenza. Acta Biochim Pol. 2014 Sep 12.
Full text 

Stanbrook MB. Review: Influenza vaccination and inhaled therapies prevent acute exacerbations in COPD. Ann Intern Med. 2015 Sep 15;163(6):JC3.

Subbarao K, Matsuoka Y. The prospects and challenges of universal vaccines for influenza.Trends Microbiol. 2013 Jul;21(7):350-8. doi: 10.1016/j.tim.2013.04.003.
Abstract

Sullivan SG, Feng S, Cowling BJ. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev Vaccines. 2014 Oct 28:1-21.
Abstract

Tomar J. et al. Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination. Expert Rev Vaccines. 2016 May 21:1-17.
Abstract

Treanor JJ. Prospects for broadly protective influenza vaccines. Vaccine. 2015 Sep 1. pii: S0264-410X(15)01181-0.
Abstract

Treanor JJ. Prospects for Broadly Protective Influenza Vaccines. Am J Prev Med. 2015 Dec;49(6 Suppl 4):S355-63.
Abstract

Tricco AC. et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013 Jun 25;11(1):153. [Epub ahead of print]
Full text

Tripp RA, Tompkins SM. Virus-Vectored Influenza Virus Vaccines. Viruses. 2014 Aug 7;6(8):3055-3079.
Full text

Udell JA. et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013 Oct 23;310(16):1711-20.
Full text

van Els C. et al. Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Hum Vaccin Immunother. 2014 Apr 24;10(7). [Epub ahead of print]
Abstract

van Riet E. et al. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. Vaccine. 2012 Aug 31;30(40):5893-900.
Abstract

Verma R, Khanna P, Chawla S. Influenza vaccine: an effective preventive vaccine for developing countries. Hum Vaccin Immunother. 2012 May;8(5):675-8.
Abstract

Virk RK, Gunalan V, Tambyah PA. Influenza infection in human host: challenges in making a better influenza vaccine. (Singapore) Expert Rev Anti Infect Ther. 2016 Feb 17.
Abstract

Wohlbold TJ, Krammer F. In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen. Viruses. 2014 Jun 23;6(6):2465-94.
Full text

Wong SS, Webby RJ. Traditional and new influenza vaccines.Clin Microbiol Rev. 2013 Jul;26(3):476-92. doi: 10.1128/CMR.00097-12.
Abstract

Wong TM, Ross TM. Use of computational and recombinant technologies for developing novel influenza vaccines. Expert Rev Vaccines. 2015 Nov 23:1-11.
Abstract

Xiang K. et al. Progress on adenovirus-vectored universal influenza vaccines. Hum Vaccin Immunother. 2015 Apr 15:0.
Abstract

Yamazaki T, Ichinohe T. Inflammasomes in antiviral immunity: clues for influenza vaccine development. Clin Exp Vaccine Res. 2014 Jan;3(1):5-11. Epub 2013 Dec 18.
Full text

Yang L.P. Recombinant trivalent influenza vaccine (flublok(®)): a review of its use in the prevention of seasonal influenza in adults. Drugs. 2013 Aug;73(12):1357-66.
Abstract

Yewdell JW. To dream the impossible dream: universal influenza vaccination. Curr Opin Virol. 2013 Jun;3(3):316-21. doi: 10.1016/j.coviro.2013.05.008. Epub 2013 Jul 5.
Abstract

Yin JK. et al. The Threat of Human Influenza: the Viruses, Disease Impacts, and Vaccine Solutions. Infect Disord Drug Targets. 2014 Oct 14.
Abstract

Yin J.K. et al. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. Vaccine. 2012 May 2;30(21):3209-22.
Abstract 

Yusibov V, Kushnir N, Streatfield SJ. Advances and challenges in the development and production of effective plant-based influenza vaccines. Expert Rev Vaccines. 2014 Dec 9:1-17.
Abstract

Zhang H, El Zowalaty ME. DNA-based influenza vaccines as immunoprophylactic agents toward universality. Future Microbiol. 2016 Jan;11:153-64.
Abstract

Zhang N. et al. Advancements in the development of subunit influenza vaccines. Microbes Infect. 2015 Feb;17(2):123-34.
Full text